Cby1 transcript levels in CD34+ cells from all six CML-CP patients were significantly lower compared with MCF and protein expression was further reduced (p<0.001 or less) (Figures 4A and B, Figure S4 and Table S4). Here, CBY1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.